Article
Myeloperoxidase is a Critical Mediator of Anthracycline-induced Cardiomyopathy
2022-12-13
Abstract excerpt
<title>Abstract</title> <p>Cardiotoxicity is a major complication of anthracycline therapy that negatively impacts prognosis. Effective pharmacotherapies for prevention of anthracycline-induced cardiomyopathy (AICM) are currently lacking. Increased plasma levels of the neutrophil-derived enzyme myeloperoxidase (MPO) predict occurrence of AICM in humans. We hypothesized that MPO release causally contributes to AIC...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d22eae65-09af-5c19-915f-aa15789ef1d2
- DOI
- 10.21203/rs.3.rs-2219349/v1
